Cure8 research brief
Why This Matters
People with Crohn’s disease or ulcerative colitis often experience anxiety, depression, and reduced quality of life; this review suggests that continuity of care programs can help improve those outcomes.
Those changes matter because better mental health and quality of life can affect daily functioning and engagement with treatment.
Who Should Pay Attention
Adult patients with IBD, caregivers, gastroenterology clinicians and nurses, and health services researchers interested in care delivery and patient-centered models.
Study Snapshot
What To Know
This systematic review and meta-analysis pooled 12 randomized controlled trials (1,246 participants) evaluating “continuity of patient care” interventions for people with inflammatory bowel disease (IBD).
The authors report that continuity of care—programs that maintain consistent patient–provider relationships and coordinated follow-up—was associated with improvements in disease-specific quality of life and reductions in anxiety and depressive symptoms, but it did not significantly change recurrence rates or nursing satisfaction.
The paper notes very high heterogeneity across included trials and downgrades overall evidence to moderate quality.
The review’s findings suggest that organizing care to improve continuity (for example, consistent clinicians, structured follow-up, and coordinated nursing support) may help patients’ mental health and quality of life, though exact program components and the size of benefit varied between studies.
Practical takeaway: Continuity-focused care approaches are promising for improving quality of life and psychological well-being in IBD, but results are heterogeneous and not definitive for affecting disease recurrence.
Clinicians and care teams may consider continuity strategies as part of comprehensive care, while researchers should test which specific elements work best.
Keep In Mind
The authors rated evidence quality as moderate due to very high heterogeneity between trials; interventions defined as “continuity of care” varied, so benefits may depend on specific program components. This brief is based on the article abstract and pooled results; it does not substitute for reading full trials or clinical guidance.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.